| 产品描述: | BTdCPU is a potent heme regulated inhibitor kinase (HRI) activator that promotes eIF2α phosphorylation and induces apoptosis in Dexamethasone (HY-14648) (Dex)-resistant cancer cells. BTdCPU can be used in the study of cancers such as multiple myeloma and Dex-resistant multiple myeloma |
| 靶点: |
HRI;Apoptosis; Phosphatase; PERK |
| 体内研究: |
BTdCPU (175 mg/kg; i.p.; single daily for 21 days) inhibits tumor growth without toxicity in mice xenograft breast tumors model. Animal Model: Female nude mice (mice xenograft breast tumors model). Dosage: 175 mg/kg Administration: Intraperitoneal injection; single daily for 21 days Result: Led to complete tumor stasis,which persisted for the remainder of the 3-week studyShowed good safety in mice. |
| 参考文献: |
1. Burwick N, et al. The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma. Leuk Res. 2017 Apr;55:23-32. 2. Chen T, et al. Chemical genetics identify eIF2α kinase heme-regulated inhibitor as an anticancer target. Nat Chem Biol. 2011 Jul 17;7(9):610-6. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-20℃ |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.948 ml |
14.741 ml |
29.481 ml |
| 5 mM |
0.59 ml |
2.948 ml |
5.896 ml |
| 10 mM |
0.295 ml |
1.474 ml |
2.948 ml |
| 50 mM |
0.059 ml |
0.295 ml |
0.59 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |